Table 1.
Patient demographics in relation to variables in the predictive score for patients managed by the warfarin care program and by a general practitioner. Data is represented as number (percentage) and median (25th and 75th percentile) for HAS-BLED (Hypertension, Abnormal renal/liver function, Stroke history, Bleeding history, Labile International Normalised Ratio, Elderly, i.e., age > 65 years, Drugs/alcohol concurrently) and CHA2DS2VASc (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes mellitus, Stroke/transient ischaemic attack, Vascular disease, Age 65-74 years, Sex – female) risk scores.
| Patient Characteristic | Warfarin Care Program (n = 3911) | General Practitioner (n = 200) |
|---|---|---|
| Gender | ||
| Female | 1901 (48.6) | 96 (48.0) |
| Male | 2010 (51.4) | 104 (52.0) |
| Age | ||
| <60 years | 150 (3.8) | 2 (1.0) |
| ≥60 years | 3761 (96.2) | 198 (99.0) |
| Medical History | ||
| More than two of the following: hypertension, diabetes, coronary artery disease/myocardial infarction, peripheral arterial disease, congestive heart failure, previous stroke, pulmonary disease, hepatic or renal disease | 254 (6.5) | 37 (18.5) |
| Concurrent Treatment Amiodarone | 220 (5.6) | 10 (5.0) |
| Tobacco Use (within 2 years) | 17 (0.4) | 0 (0) |
| Race | N/A | N/A |
| HAS-BLED | 1 (1–2) | 2 (1–2) |
| CHA2DS2VASc | 3 (2–4) | 3 (2–4) |